Top 10 Pharma Companies in South Korea by Market Cap

Celltrion Inc, SK Bioscience Ltd, SK Biopharmaceuticals Co Ltd, Yuhan Corp, and Hanmi Pharmaceuticals Co Ltd are the top 5 pharma companies in South Korea in 2023 by market capitalization (as of Mar 31, 2023). Comprehensively, the top 10 Pharma companies in South Korea had a total market cap of $35,985 million (as of Mar 31, 2023), with Celltrion Inc having the highest ($16,907 million), followed by SK Bioscience Ltd ($4,270 million), and SK Biopharmaceuticals Co Ltd ($3,823 million), while Shin Poong Pharm Co Ltd is the lowest ($789 million). Celltrion Inc is the leading Pharma company by market cap in South Korea (as of Mar 31, 2023). The company reported revenues of $1,671 million for the fiscal year ended December 2021 (FY2021), an increase of 6.5% over FY2020. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn’s disease, psoriatic arthritis, and psoriasis. It employs 1,074 people. SK Bioscience Ltd is another leading Pharma company in South Korea by market cap (as of Mar 31, 2023). The company reported revenues of $354 million for the fiscal year ended December 2022 (FY2022), a decrease of 56.4% over FY2021. It is a biotechnology company that develops and manufactures vaccines for infectious diseases. The company offers injection solutions and medicines to prevent diphtheria, tetanus, hepatitis B, pertussis, meningococcal, human papillomavirus, measles, mumps, and rubella; and syringes to administer vaccines. It employs 1,067 people.